CircoMax Myco Europäische Union - Deutsch - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologische tests für suidae - schweine (mast) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Europäische Union - Deutsch - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - impfstoffe - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Europäische Union - Deutsch - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenza-virus-oberflächenantigene (hämagglutinin und neuraminidase) des stammes a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - impfstoffe - aktive immunisierung gegen den h5n1-subtyp des influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

BTVPUR BTV 4 ad us. vet. suspension injectable pour ovins et bovins Schweiz - Deutsch - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

btvpur btv 4 ad us. vet. suspension injectable pour ovins et bovins

biokema s.a. - inactivated bluetongue virus, serotype 4 - suspension injectable pour ovins et bovins - inactivated bluetongue virus, serotype 4 1.86 log10 u., aluminii oxidum hydricum 2.7 mg, saponinum 30 u., ad suspensionem pro dosi 1 ml. - vaccin inactivé contre l’orbivirus bovin (maladie de la langue bleue) chez les bovins et ovins - impfstoffe

Zulvac 1+8 Ovis Europäische Union - Deutsch - EMA (European Medicines Agency)

zulvac 1+8 ovis

zoetis belgium sa - inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01, inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 - bluetongue virus, sheep, inactivated viral vaccines - schaf - aktive immunisierung von schafen von 1. 5 monate alt, um einer virämie vorzubeugen, die durch das blauzungenvirus, serotypen 1 und 8, verursacht wird. beginn der immunität: 21 tage nach abschluss der grundimmunisierung. dauer der immunität: 12 monate.

Bovalto Respi 3 Injektionssuspension Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bovalto respi 3 injektionssuspension

boehringer ingelheim animal health belgium - bovine respiratory-synctial-virus (brsv); parainfluenza-3-virus; mannheimia haemolytica, inactivated - injektionssuspension - bovine respiratory-synctial-virus (brsv) ; parainfluenza-3-virus ; mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - rind

Bovalto Respi 4 Injektionssuspension Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bovalto respi 4 injektionssuspension

boehringer ingelheim animal health belgium - bovine respiratory-synctial-virus (brsv); parainfluenza-3-virus; bovine virus diarrhoe (bvd); mannheimia haemolytica, inactivated - injektionssuspension - bovine respiratory-synctial-virus (brsv) ; parainfluenza-3-virus ; bovine virus diarrhoe (bvd) ; mannheimia haemolytica, inactivated - inactivated viral and inactivated bacterial vaccines - rind

Hiprabovis Somni/LKT Emulsion zur Injektion Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hiprabovis somni/lkt emulsion zur injektion

laboratorios hipra - histophilus somni, inaktiviert; mannheimia haemolytica, inactivated - emulsion zur injektion - histophilus somni, inaktiviert ; mannheimia haemolytica, inactivated - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - rind

RP Vacc Emulsion zur Herstellung einer Emulsion zur Injection Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rp vacc emulsion zur herstellung einer emulsion zur injection

pharmagal - rotavirus pigeon, inactivated; paramyxovirus type 1 pigeon, inactivated - emulsion zur herstellung einer emulsion zur injection - rotavirus pigeon, inactivated ; paramyxovirus type 1 pigeon, inactivated - inactivated viral vaccines - taube

Scourguard 3 Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

scourguard 3 lyophilisat und lösungsmittel zur herstellung einer injektionslösung

zoetis belgium - escherichia coli, inactivated, strain nadc 1471 0101, fimbrial adhesins f5; bovine coronavirus; bovine rotavirus - lyophilisat und lösungsmittel zur herstellung einer injektionslösung - escherichia coli, inactivated, strain nadc 1471 0101, fimbrial adhesins f5 ; bovine coronavirus ; bovine rotavirus - live bovine rotavirus + live bovine coronavirus + inactivated escherichia - rind